Effect of edaravone injection combined with salvianolate on cerebral hemodynamics of patients with cerebral infarction
-
摘要: 目的 观察依达拉奉注射液联合丹参多酚酸盐对脑梗死患者脑血流动力学的影响.方法 106例脑梗死患者随机分为2组.对照组给予降压、脱水和抗凝等常规治疗并静脉滴注依达拉奉注射液.联合治疗组在对照组基础上静脉滴注注射用丹参多酚酸盐.比较2组患者治疗前后全血低切黏度、全血高切黏度、血细胞比容、血浆黏度等血液流变指标;比较2组患者治疗前后最大峰值流速、舒张末流速、血管搏动指数和血管阻力指数等脑血流动力学指标变化;采用欧洲卒中量表(ESS)计算神经功能缺损评分分值及总有效率.结果 联合给药组治疗后ESS分值及总有效率显著优于对照组(P＜0.05),血液流变学和脑血流动力学各指标均显著优于对照组(P＜0.05).结论 依达拉奉与丹参多酚酸盐两药联用治疗脑梗死可以降低脑梗死患者血液黏滞度,改善脑血流动力学.Abstract: Objective To explore the effect of edaravone injection combined with salvianolate on cerebral hemodynamics of patients with cerebral infarction.Methods A total of 106 patients with cerebral infarction were selected and randomly divided into two groups.The control group was given antihypertensive,dehydration and anticoagulation therapy and intravenous infusion of edaravone injection.Combined treatment group was given intravenous infusion of salvianolate on the basis of the control group.The platelet aggregation rate,whole blood viscosity,whole blood low shear viscosity,plasma viscosity,hematuria,peak flow rate,end-diastolic flow velocity,pulsatility index and vascular resistance indexes before and after treatment were compared between two groups.The total effective rate and neurological deficit scores were evaluated after treatment by the European Stroke Scale (ESS).Results The ESS score and the total effective rate of the combined treatment group were significantly better than the control group,and the indexes of hemorheology were significantly better than the control group (P ＜ 0.05).Conclusion The edaravone injection combined with salvianolate can reduce blood viscosity and improve cerebral hemodynamics in patients with cerebral infarction.
-
Keywords:
- edaravone /
- salvianolate /
- cerebral infarction /
- regional cerebral blood flow /
- hemorheology
-
-
期刊类型引用(11)
1. 刘亚男，房志琴，郭健宏，王亚玲. 冠状动脉慢血流患者血清Lp-PLA_2、NLR水平变化及临床意义. 广东医学. 2024(06): 717-722 . 
百度学术
2. 朱雅男，张志强，徐继方，朱云霞，安梦秋. 冠状动脉慢血流的相关血清学分析. 心肺血管病杂志. 2023(01): 23-26 . 百度学术
3. 孙晓慧，贺静，王瑶，白蓉，薛晓珍，杨莉，乌宇亮. 血清脂蛋白相关磷脂酶A2水平与冠状动脉病变程度及慢血流的相关性分析. 临床医学研究与实践. 2023(26): 9-12 . 百度学术
4. 师志芳，贾营，张秀敬，谭化，王爱民，赵洁. 血清血小板活化因子和脂蛋白相关磷脂酶AA2对冠状动脉慢血流现象的预测价值分析. 中国心血管病研究. 2023(12): 1080-1085 . 百度学术
5. 梁万添，唐良秋，陈锦峰，庞军刚，周婉明，陈伟强，陈姣. 小檗碱对急性心肌梗死经皮冠状动脉介入术后冠状动脉不稳定斑块的治疗作用. 中国医药. 2021(01): 28-32 . 百度学术
6. 刘玲玲，韩磊. 冠状动脉慢血流与超敏CRP及左室舒张功能的相关性研究. 中国医药指南. 2021(22): 11-13 . 百度学术
7. 朱宝华，孙岩. 冠状动脉疾病差异基因富集和加权基因共表达网络分析. 实用临床医药杂志. 2021(17): 15-21 . 本站查看
8. 陶金松，李健，徐霞，陆翊超，李伟章. 冠心病患者介入术中并发冠状动脉慢血流的影响因素. 现代医学与健康研究电子杂志. 2021(19): 93-95 . 百度学术
9. 陆爱民，童有福，赵艳. 利伐沙班对冠状动脉慢血流患者凝血功能及C反应蛋白的影响. 医学综述. 2021(21): 4354-4359 . 百度学术
10. 孙涛，张艳丽，侯梅凤，姚成俊，潘闽. 血清脂蛋白(a)[Lp(a)]、血清超敏C反应蛋白（hs-CRP）与冠状动脉慢血流之间的相关性. 系统医学. 2021(22): 32-36 . 百度学术
11. 陈艳俏，程伟，张成英，陈少军，马友合，孙久林. 保元汤合桂枝茯苓丸治疗冠状动脉慢血流临床观察. 中国中医药现代远程教育. 2020(19): 70-73 . 百度学术
其他类型引用(0)
计量
- 文章访问数: 332
- HTML全文浏览量: 91
- PDF下载量: 5
- 被引次数: 11
下载:
苏公网安备 32100302010246号
